US › Healthcare

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$18.48-1.96%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$722.5M
Revenue YoY
+3.9%
Net profit
$62.5M
Profit YoY
+412.5%
EPS
$0.27
EPS estimate
$0.19
Net margin
8.6%

EPS came in at 0.27 against a street estimate of 0.19 — a beat of 39.0%.

Key statistics

Market cap
$6.02B
P/E
39.3
Forward P/E
6.3
P/B
177.20
Book value
$0.10
EPS (TTM)
$0.48
52-week high
$19.26
52-week low
$7.98
50-day MA
$16.06
200-day MA
$13.48
Beta
1.25

Analyst view

Analysts rate Amneal Pharmaceuticals, Inc. Class A Common Stock a buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $18.75.

Shareholding

Insiders
49.04%
Institutions
52.35%

Largest institutional holders

FundStake
BlackRock Inc7.68%
Vanguard Group Inc5.61%
TPG GP A, LLC3.86%
Vanguard Portfolio Management, LLC3.55%
Rubric Capital Management LP3.46%
Vanguard Capital Management, LLC2.38%
State Street Corp2.13%
Dimensional Fund Advisors, Inc.1.78%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Amneal Pharmaceuticals, Inc. Class A Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.